Canine rabies DNA vaccination: A single-dose intradermal injection into ear pinnae elicits elevated and persistent levels of neutralizing antibody

Vaccine

Volumn 21, Issue 25-26, 2003, Pages 3998-4002

  Lodmell, Donald L ^a   Parnell, Michael J ^a   Weyhrich, John T ^b   Ewalt, Larry C ^a  

^a NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES   (United States)

^b UNIVERSITY OF MONTANA   (United States)

Author keywords

Canine rabies; Ear pinnae; Vaccination

Indexed keywords

DNA VACCINE; NEUTRALIZING ANTIBODY; RABIES VACCINE;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CONCENTRATION (PARAMETERS); CONTROLLED STUDY; DOG; DRUG EFFECT; EXTERNAL EAR; FEMALE; IN VIVO STUDY; INJECTION; NECK; NONHUMAN; PRIORITY JOURNAL; PROVOCATION TEST; QUADRICEPS FEMORIS MUSCLE; RABIES; RABIES VIRUS; SERUM; SINGLE DRUG DOSE; VACCINATION;

EID: 0242380404     PISSN: 0264410X     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0264-410X(03)00297-4     Document Type: Article

References (24)

1. Wilkinson L. Understanding the nature of rabies: an historical perspective. In: Campbell JB, Chariton KM, editors. Rabies. Boston: Kluwer Academic Publishers; 1988. p. 1-23.
2. Smith J.S., Seidel H.D. Rabies: a new look at an old disease. Prog. Med. Virol. 40:1993;82-106.
3. Dressen D.W. A global review of rabies vaccines for human use. Vaccine. 15(Suppl):1997;S2-S6.
4. Meslin F, Fishbien DB, Matter HC. Rationale and prospects for rabies elimination in developing countries. In: Rupprecht CE, Dietzschold B, Koprowski H, editors. Lyssaviruses. New York: Springer Verlag; 1994. p. 1-26.
5. Meslin F. Gloval review of human and animal rabies. In: Rabies: guidelines for medical professionals. Trenton, NJ: Veterinary Learning Systems; 1999. p. 9-11.
6. Lodmell D.L., Ray N.B., Ewalt L.C. Gene gun particle-mediated vaccination with plasmid DNA confers protective immunity against rabies virus infection. Vaccine. 16:1998;115-118.
7. Ray N.B., Ewalt L.C., Lodmell D.L. Nanogram quantities of plasmid DNA encoding the rabies virus glycoprotein protect mice against lethal rabies virus infection. Vaccine. 15:1997;892-895.
8. Lodmell D.L., Ray N.B., Parnell M.J., Ewalt L.C., Hanlon G.A., Shaddock J.H.et al. DNA immunization protects non-human primates against rabies virus. Nat. Med. 4:1998;949-952.
9. Lodmell D.L., Parnell M.J., Bailey J.R., Ewalt L.C., Hanlon C.A. One-time gene gun or intramuscular rabies DNA vaccination of non-human primates: comparison of neutralizing antibody responses and protection against rabies virus 1 year after vaccination. Vaccine. 20:2001;838-844.
10. Xiang Z.Q., Spitalnik S., Tran M., Wunner W.H., Cheng J., Ertl H.G. Vaccination with a plasmid vector carrying the rabies virus glycoprotein gene induces protective immunity against rabies virus. Virology. 199:1994;132-140.
11. Xiang Z.Q., Spitalnik S.L., Cheng J., Erikson J., Wojczyk B., Ertl H.G. Immune responses to nucleic acid vaccines to rabies virus. Virology. 209:1995;569-579.
12. Lodmell D.L., Ewalt L.C. Post-exposure DNA vaccination protects mice against rabies virus. Vaccine. 19:2001;2468-2473.
13. Lodmell D.L., Ewalt L.C. Rabies vaccination: comparison of neutralizing antibody responses after priming and boosting with different combinations of DNA, inactivated virus, or recombinant vaccinia virus vaccines. Vaccine. 18:2000;2394-2398.
14. Wang Y., Xiang Z., Pasquiru S., Ertl H.C.J. Effect of passive immunization or maternally transferred immunity on the antibody response to a genetic vaccine to rabies virus. J. Virol. 72:1998;1790-1796.
15. Osorio J.E., Tomlinson C.C., Frank R.S., Haanes E.J., Rushlow K., Haynes J.R.et al. Immunization of dogs and cats with a DNA vaccine against rabies virus. Vaccine. 17:1999;1109-1116.
16. Perrin P., Jacob Y., Aguilar-Setien A., Loza-Rubio E., Jallet C., Desmezieres E.et al. Immunization of dogs with a DNA vaccine induces protection against rabies virus. Vaccine. 18:2000;479-486.
17. Lodmell D.L., Ray N.B., Ulrich J.T., Ewalt L.C. DNA vaccination of mice against rabies virus: effects of the route of vaccination and the adjuvant monophosphoryl lipid A (MPL). Vaccine. 18:2000;1059-1066.
18. Lodmell D.L., Parnell M.J., Bailey J.R., Ewalt L.C., Hanlon C.A. Rabies DNA vaccination of non-human primates: post-exposure studies using gene gun methodology that accelerates induction of neutralizing antibody and enhances neutralizing antibody titers. Vaccine. 20:2002;2221-2228.
19. Forg P., von Hoegen P., Dalemans W., Schirrmacher V. Superiority of the ear pinna over muscle tissue as site for DNA vaccination. Gene Ther. 5:1998;789-797.
20. Akbari O., Panjwani N., Garcia S., Tascon R., Lowrie D., Stockinger B. DNA vaccination: transfection and activation of dendritic cells as key events for immunity. J. Exp. Med. 189:1999;169-178.
21. Krieg A.M. Immune effects and mechanisms of action of CpG motifs. Vaccine. 19:2000;618-622.
22. Krieg A.M. From bugs to drugs: therapeutic immunomodulation with oligodeoxynucleotides containing CpG sequences from bacterial DNA. Antisense Nucleic Acid Drug Dev. 11:2001;181-188.
23. Verthelyi D., Kenney R.T., Seder R.A., Gam A.A., Friedag B., Klinman D.M. CpG oligodeoxynucleotides as vaccine adjuvants in primates. J. Immunol. 168:2002;1659-1663.
24. Herve M., Dupre L., Ban E., Schacht A.-M., Capron A., Riveau G. Features of the antibody response attributable to plasmid backbone adjuvanticity after DNA immunization. Vaccine. 19:2001;4549-4556.